The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122825124 12282512 4 F 20150121 20160729 20160419 20160809 EXP JP-ALEXION PHARMACEUTICALS INC-A201602912 ALEXION 68.00 YR F Y 0.00000 20160809 PH JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122825124 12282512 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, SINGLE 15300 MG Y 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
122825124 12282512 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, SINGLE 15300 MG Y 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
122825124 12282512 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, QW 15300 MG Y 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION /wk
122825124 12282512 4 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, Q2W 15300 MG Y 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
122825124 12282512 5 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, SINGLE 15300 MG Y AC6841D01 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
122825124 12282512 6 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q4W 15300 MG Y AD6547B01 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION
122825124 12282512 7 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q5W 15300 MG Y AD7700B01 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION
122825124 12282512 8 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q5W 15300 MG Y AE3116D01 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION
122825124 12282512 9 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, UNK 15300 MG Y 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION
122825124 12282512 10 C NESP DARBEPOETIN ALFA 1 Intravenous (not otherwise specified) 120 ?G, QW 0 120 UG INJECTION /wk
122825124 12282512 11 C GRAN FILGRASTIM 1 Subcutaneous 75 ?G, PRN 0 75 UG INJECTION /yr
122825124 12282512 12 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 20 MG, QD 0 20 MG QD
122825124 12282512 13 C FEBURIC FEBUXOSTAT 1 Unknown UNK 0
122825124 12282512 14 C BAYASPIRIN ASPIRIN 1 Oral 100 MG, QD 0 100 MG QD
122825124 12282512 15 C ATORVASTATIN ATORVASTATIN 1 Oral 5 MG, QD 0 5 MG QD
122825124 12282512 16 C PHOSBLOCK FERRIC HYDROXIDE 1 Oral 250 MG, QD 0 250 MG QD
122825124 12282512 17 C GASMOTIN MOSAPRIDE CITRATE 1 Oral 5 MG, TID 0 5 MG TID
122825124 12282512 18 C ARGAMATE CALCIUM POLYSTYRENE SULFONATE 1 Oral 5 G, QD 0 5 G QD
122825124 12282512 19 C SENNOSIDE /00571901/ SENNOSIDES A AND B 1 Oral 12 MG, QD 0 12 MG QD
122825124 12282512 20 C NAUZELIN DOMPERIDONE 1 Oral 10 MG, TID 0 10 MG TID
122825124 12282512 21 C MIYA-BM CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 1 Oral 2 DF, TID 0 2 DF TID
122825124 12282512 22 C FESIN /00023550/ IRON SUCROSE 1 Intravenous drip 40 MG, TIW 0 40 MG INJECTION TIW

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122825124 12282512 1 Haemolytic uraemic syndrome
122825124 12282512 10 Nephrogenic anaemia
122825124 12282512 11 White blood cell count decreased
122825124 12282512 12 Gastritis
122825124 12282512 13 Hyperuricaemia
122825124 12282512 14 Thrombosis
122825124 12282512 15 Dyslipidaemia
122825124 12282512 16 Hyperphosphataemia
122825124 12282512 17 Gastritis
122825124 12282512 18 Hyperkalaemia
122825124 12282512 19 Constipation
122825124 12282512 20 Nausea
122825124 12282512 21 Constipation
122825124 12282512 22 Iron deficiency anaemia

Outcome of event

Event ID CASEID OUTC COD
122825124 12282512 HO
122825124 12282512 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122825124 12282512 Inappropriate schedule of drug administration
122825124 12282512 Incorrect dose administered
122825124 12282512 Pneumonia
122825124 12282512 Shunt stenosis
122825124 12282512 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122825124 12282512 1 20150117 20150117 0
122825124 12282512 2 20150121 20150121 0
122825124 12282512 3 20150124 20150206 0
122825124 12282512 4 20150213 20150619 0
122825124 12282512 5 20150710 20150710 0
122825124 12282512 6 20150731 20151125 0
122825124 12282512 7 20151221 0
122825124 12282512 8 20160302 0
122825124 12282512 10 20141001 0
122825124 12282512 11 20150413 20151023 0
122825124 12282512 12 20151203 0
122825124 12282512 13 20150810 0
122825124 12282512 14 20150820 0
122825124 12282512 15 20160216 0
122825124 12282512 16 20160512 0
122825124 12282512 17 20150414 0
122825124 12282512 18 20160512 0
122825124 12282512 19 20141010 0
122825124 12282512 20 20140913 0
122825124 12282512 21 20140905 0
122825124 12282512 22 20160509 20160513 0

Execution Time: 0.0081548690795898 seconds (ucode:5044236). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.